Guidelines of integrated Chinese and western medicine for diagnosis and treatment of chronic obstructive pulmonary disease (2022)
Journal of Evidence-Based Medicine · 2023-12 · 16 (4) · 565-580
DOI: 10.1111/jebm.12578 ↗Kurz gefasst
Leitlinie in der Zeitschrift Journal of Evidence-Based Medicine, online erschienen am 21.12.2023. Verfasst von Jiansheng Li und 3 weiteren Autor:innen. Beteiligte Einrichtung: Co-Construction Collaborative Innovation Center for Chinese Medicine and Respiratory Diseases by Henan & Education Ministry of China, Henan Universit…. Hauptthemen laut MEDLINE: Pulmonary Disease, Chronic Obstructive. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 86 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Key Research & Development Program of China, Inheritance and Innovation BaiQianWan Talents Project-Chief Scientist Project of Qihuang Project, Administration of Traditional Chinese Medicine of China: Traditional Chinese Medicine Inheritance and Innovation Team Project.
Themen: COPD
Abstract (Originalsprache)
Chronic obstructive pulmonary disease (COPD), with high prevalence rate, mortality, disability rate, and heavy disease burden, has become a critical chronic disease seriously threatening public health worldwide. Traditional Chinese medicine and Western medicine both have shown advantages in diagnosing and treating COPD, which has been widely applied in the clinics. In order to improve the diagnostic and treatment level for COPD with integrated traditional Chinese and Western medicine, the Guidelines of Integrated Chinese and Western Medicine for Diagnosis and Treatment of COPD were developed by the Internal Medicine Committee of the World Federation of Chinese Medicine Societies. First, a multidisciplinary working group was established. Development methods and processes of international clinical practice guidelines were adopted in the whole research. In final, a total of 13 recommendations for the diagnosis and treatment of COPD were established based on available evidence with the best quality. Meanwhile, characteristics of integrated traditional Chinese and Western medicine in treating COPD were taken into account with pros and cons of each intervention. The guidelines could be used as a reference for physicians in respiratory medicine departments (traditional Chinese medicine, integrated traditional Chinese and Western medicine, and Western medicine) at various levels of medical institutions in their diagnosis and treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Co-Construction Collaborative Innovation Center for Chinese Medicine and Respiratory Diseases by Henan & Education Ministry of China, Henan University of Chinese Medicine, Zhengzhou, China.
- Henan Key Laboratory of Chinese Medicine for Respiratory Disease, Henan University of Chinese Medicine, Zhengzhou, China.
- Department of Respiratory Diseases, the First Affiliated Hospital of Henan University of Chinese Medicine, Zhengzhou, China.
- Shenzhen Institute of Respiratory Diseases, Shenzhen People's Hospital, Shenzhen, China.
- Department of Respiratory Diseases, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
ORCID-Profile: Jiansheng Li, Xueqing Yu
Förderung
- National Key Research & Development Program of China
- Inheritance and Innovation BaiQianWan Talents Project-Chief Scientist Project of Qihuang Project
- Administration of Traditional Chinese Medicine of China: Traditional Chinese Medicine Inheritance and Innovation Team Project
Zitieren
APA
Li, J., Chen, R., Yu, X., & Liu, H. (2023). Guidelines of integrated Chinese and western medicine for diagnosis and treatment of chronic obstructive pulmonary disease (2022). Journal of Evidence-Based Medicine, 16(4), 565-580. https://doi.org/10.1111/jebm.12578
Vancouver
Li J, Chen R, Yu X, Liu H. Guidelines of integrated Chinese and western medicine for diagnosis and treatment of chronic obstructive pulmonary disease (2022). Journal of Evidence-Based Medicine. 2023;16(4):565-580. doi:10.1111/jebm.12578
BibTeX
@article{Li2023,
author = {Li, Jiansheng and Chen, Rongchang and Yu, Xueqing and Liu, Huiguo},
title = {Guidelines of integrated Chinese and western medicine for diagnosis and treatment of chronic obstructive pulmonary disease (2022)},
journal = {Journal of Evidence-Based Medicine},
year = {2023},
volume = {16},
number = {4},
pages = {565--580},
doi = {10.1111/jebm.12578}
}
EUVIMED